Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
about
MicroRNA-122 modulates the rhythmic expression profile of the circadian deadenylase Nocturnin in mouse liver.microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinomaMicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolismMicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibRole of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 miceMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaHepatic Stellate Cells and microRNAs in Pathogenesis of Liver FibrosisMicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaNovel Molecular Mechanisms in the Development of Non-Alcoholic SteatohepatitisCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaMicroRNAs in Nonalcoholic Fatty Liver Disease'Micro-managers' of hepatic lipid metabolism and NAFLDEpigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutritionRole of regulatory micro RNAs in type 2 diabetes mellitus-related inflammationMicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseasemiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimirIntercellular transport of microRNAsNeedles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulomeMicroRNAs in fibrosis: opportunities and challengesMolecular Pathogenesis of NASHPathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsBiomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?Bile acid signaling in metabolic disease and drug therapyDifference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in miceCirculating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injuryMulti-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver diseaseHypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.The effect of exposure to a high-fat diet on microRNA expression in the liver of blunt snout bream (Megalobrama amblycephala)Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field.MicroRNAs in adipogenesis and as therapeutic targets for obesity.MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Prolonged exposure to low-dose microcystin induces nonalcoholic steatohepatitis in mice: a systems toxicology study.Impact of embryo number and maternal undernutrition around the time of conception on insulin signaling and gluconeogenic factors and microRNAs in the liver of fetal sheepLiver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.MicroRNAs in metabolism and metabolic disordersFoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis.Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening.TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.
P2860
Q21136339-8BE8E0DD-BC94-4F6D-B010-A299C4F76E94Q24595141-357DF44E-F968-465D-B5F1-870FE62EC157Q24629354-AE00E7CA-CFC3-401D-9124-ED4A1885251FQ24655048-8BC30732-884E-4C4F-95E7-D2A85D2854ABQ24657152-1A7CAAE2-D9F7-4ED5-AB77-7052ED966DA4Q26750448-E565B4C8-1588-43D6-99CC-C5D423348262Q26751392-150D7F73-0A93-48CD-A252-27D72C54DF04Q26752932-E77477C9-9048-46DC-B598-A7FAB65579C7Q26765476-5102D1AE-BC34-4744-8FB3-25740B308F81Q26766533-3E1073DB-3F82-4FD8-B31F-8AD6E9AA0DD7Q26767346-AC413365-6F53-4BC9-B4EA-2F538F49446BQ26774294-AEAF9B4A-42C0-43CC-8796-DB4C9332E66EQ26801228-91898D3D-955C-4CEC-995A-E384FCF0F454Q26822513-C53D254E-4A34-4EE5-995A-FC128279846DQ26830676-26DAB3BA-93CC-43C4-A9F3-523A576C1909Q26852606-CFEBE5F1-780E-402C-84E3-C7342EF05800Q26991956-7A57605C-2E66-4D31-851B-EF44E399DA79Q27004360-50FA90EA-EA93-4D0C-AEEE-63C8252C40FCQ27015035-5A86C9B4-182D-48D1-AE54-EEAF4D8B55AAQ28067380-17F7A2CA-EFE4-4994-BAA5-C3A976CB7F63Q28071265-3B691966-69ED-4CFD-B0D8-C212DAE0AA1FQ28071596-8811C65A-B58D-4CB1-ACB8-99422928A78FQ28084035-FA688976-4976-480F-8C43-07CB19229870Q28244875-CAB6D802-21CA-4508-87D6-9EDAFEB77506Q28507402-DDB6573B-06DA-4910-819F-61F276847CCFQ28533876-4307CB18-5E95-4CB5-965B-E6257533C74EQ30000787-CADC997A-22FA-4CAD-9C02-15428CE0D437Q30251565-2419CE4A-0AC4-4453-BA4B-73D4FED36026Q30391726-32CD08D3-F36F-427C-8321-A29678842722Q30400120-857982EC-F9E2-4A2C-8275-3218A16E5EA4Q30400205-DE36FE40-69A3-4B1B-92A4-785A2A218911Q30439971-15EF6897-7FD9-4036-B614-7ECEC15522D8Q31059395-01BDB83E-848F-48F4-8C98-61A7064D2518Q33568682-500AF211-07F8-4B47-82A4-8378A173315CQ33588984-61A3F338-8F9F-4B93-B713-EC623BA945FFQ33612997-F4818C1F-7E1C-4F18-8F87-A1E88BA57DE8Q33613352-D8C41CBE-88B7-40FD-BBF8-B94ED1486AB8Q33635237-A54C7AC7-7A4C-4412-9C80-FD7264479F77Q33754007-82611497-3346-4813-99AF-8CA69719DCB3Q33759921-6D857732-FF70-43B9-8D8F-B5BF6714871B
P2860
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@en
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@nl
type
label
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@en
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@nl
prefLabel
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@en
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@nl
P2093
P2860
P356
P1433
P1476
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.
@en
P2093
Arun J Sanyal
Christoph Eicken
Faridoddin Mirshahi
James W Maher
John M Kellum
Melissa J Contos
Onpan Cheung
Puneet Puri
Velimir A Luketic
P2860
P304
P356
10.1002/HEP.22569
P407
P577
2008-12-01T00:00:00Z